Cite
HARVARD Citation
Yu, C. et al. (2020). Co-infusion of high-dose haploidentical donor cells and CD19-targeted CART cells achieves complete remission, successful donor engraftment and significant CART amplification in advanced ALL. Therapeutic advances in medical oncology. p. . [Online].